Skip to main content
. 2021 Sep 27;102(2):605–652. doi: 10.1152/physrev.00005.2021

FIGURE 2.

FIGURE 2.

Completed clinical trials with potential antifibrotics grouped by mechanism of action, phase of development, and mode of administration. ECM, extracellular matrix; HMG-CoA, 5-hydroxy-3-methylglutaryl-coenzyme A; RAS, renin-angiotensin system.